Astria Therapeutics, Inc. ATXS 深 沪
已收盘 01-23 16:00:00 美东时间
12.58
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 12.58
- 总市值 7.18亿
- 52周最高 13.29
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 3.555
- 委 比 0.00%
- 总股本 5708.48万
- 历史最高 1017.60
- 量 比 0
- 振 幅 0.00%
- 历史最低 2.36
- 每 手 1
- 风险率 3.10%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Astria Therapeutics Says Complaints Filed Against Astria In New York Supreme Court; Complaints Allege Negligence & Negligent Misrepresentation & Concealment Against Astria & Board; Believes That Claims Asserted In Complaints Are Without Merit
As previously disclosed, on October 14, 2025, Astria Therapeutics, Inc., a Delaware corporation ("Astria"), BioCryst Pharmaceuticals, Inc., a Delaware corporation ("BioCryst"), and Axel Merger Sub, Inc., a Delaware
2025-12-24 06:31
Cantor Fitzgerald Downgrades Astria Therapeutics to Neutral
Cantor Fitzgerald analyst Steven Seedhouse downgrades Astria Therapeutics (NASDAQ:ATXS) from Overweight to Neutral.
2025-11-13 03:06
Astria Therapeutics Q3 EPS $(0.55) Misses $(0.41) Estimate, Sales $706.000K.
Astria Therapeutics (NASDAQ:ATXS) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate of $(0.41) by 34.8 percent. This is a 30.95 percent decrease over losses of $(0.42) per share
2025-11-12 21:06
Astria Therapeutics ALPHA-STAR Phase 1b/2 Study Evaluating Navenibart Monoclonal Antibody Inhibitor In Hereditary Angioedema Participants Shows Robust Attack Rate Reduction, Favorable Safety, Tolerability Profile
Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced positive results from the full enrollment group of
2025-11-06 21:14
美股大行评级 | 贝莱德、花旗、摩根大通、富国银行均获上调目标价！汇丰上调超微公司目标价升至310美元
今日重点评级关注：Roth Capital：维持Cingulate"买入"评级，目标价从10美元升至17美元；JMP证券：维持BioCryst Pharma"跑赢大市"评级，目标价从17美元升至27美元
2025-10-16 10:43
JMP Securities Downgrades Astria Therapeutics to Market Perform
JMP Securities analyst Jonathan Wolleben downgrades Astria Therapeutics (NASDAQ:ATXS) from Market Outperform to Market Perform.
2025-10-15 19:18
美股大行评级 | 麦格理首予哔哩哔哩"跑赢大市"评级，目标价36.03美元； 高盛首予联合健康集团"买入"评级，目标价406美元
今日重点评级关注：摩根士丹利：上调Alvotech评级至"超配"，目标价14美元；蒙特利尔银行：维持PG&E"跑赢大市"评级，目标价从23美元升至25美元
2025-10-15 18:20
美股牛股 | Nova Minerals隔夜大涨110.3%！阿拉斯加项目受特朗普政府青睐；纳微半导体隔夜涨26.1%
Nova Minerals隔夜大涨110.3%！阿拉斯加项目受特朗普政府青睐；纳微半导体隔夜涨26.1%，为英伟达AI平台开发800VDC功率器件取得进展>>
2025-10-15 17:23
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Strata Skin Sciences (NASDAQ:SSKN) shares increased by 44.9% to $2.23 ...
2025-10-15 01:06
Domino's Pizza Posts Upbeat Results, Joins Astria Therapeutics, Albertsons Companies, Polaris And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Dow Jones index falling around 300 points on T...
2025-10-14 22:15
